What can Big Pharma learn from an NYT bestseller?

What do blockbuster drugs have in common with Harry Potter and Lisbeth Salander? They're all mega-sellers in industries in which only two of every 7 big, risky bets pans out. So, Big Pharma could learn a trick or two from publishers, the Financial Times posits. Report